GLOBAL MOLECULAR GENETIC TESTING FOR AUTOIMMUNE DISEASES MARKET (2024 - 2030)
The Global Molecular Genetic Testing for Autoimmune Diseases Market was valued at USD 700 million and is projected to reach a market size of USD 984.97 million by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 5%.
Molecular genetic testing is a subset of genetic testing that examines the composition and arrangement of human genes in a lab setting. For autoimmune illnesses, molecular genetic testing can be used to both identify and forecast the likelihood of having an autoimmune disease. In the past, this market had a limited presence because of its limited database, knowledge, and tools. Presently, this market has achieved a notable boost owing to technological advancements, R&D activities, and increased initiatives. In the future, with a growing focus on personalized medicine, expanded testing facilities, and rising investments, this market will experience good growth.
Key Market Insights:
Approximately 2.2 million genetic tests were conducted globally in 2022 to employ precision medicine for medical treatments. This number is expected to rise to around 5.5 million by 2027.
Approximately 11.6 billion US dollars were allocated to the NIH for genetics for the fiscal year 2022.
PCR is predicted to hold a 43.3 percent market share in molecular diagnostics by 2031.
By 2030, the global market for diagnostics for autoimmune diseases is expected to be valued at $9.98 billion.
More than half of the population, out of 8.1 billion people, lacks access to basic healthcare facilities. To tackle this, measures are being taken by institutes, organizations, and governmental bodies through investments and awareness programs. Besides, strategies are being created to reduce the cost of healthcare expenses.
Molecular Genetic Testing for Autoimmune Diseases Market Drivers:
An increasing prevalence of diseases has been fueling market growth.
Over the years, numerous changes have been observed in the standard of living and consumer preferences. This includes alterations in diets, exposure to harmful radiation, and other environmental factors. A few autoimmune diseases like multiple sclerosis, rheumatoid arthritis, type 1 diabetes, Crohn's disease, psoriasis, and lupus have seen an upsurge in incidence due to these variations. Besides, genetic alterations have been contributing to this. Autoimmune disorders cannot be cured but controlled. Therefore, there has been a significant rise in awareness through various modes and platforms. Social media has been playing a huge role in highlighting the warning signs, treatments, awareness month, symptoms, etc. Secondly, educational campaigns and training programs are being conducted to shed light on these issues. Furthermore, quarterly checkups are being encouraged for prevention and diagnosis.
Technological advancements have been accelerating the expansion.
Bioinformatics has played a vital role in gathering and generating many databases to broaden human understanding. This data is used for the prediction of genetic diseases right from the fetal stage itself. Various tools are available in this category to aid in sequencing. Additionally, integration with artificial intelligence and machine learning technologies has improved the accuracy of the diagnostics. Secondly, next-generation sequencing (NGS) helps with the rapid sequencing of genomes to generate thousands of base pairs of DNA, RNA, and mutant variation. Thirdly, biological molecules in complex samples can be identified and quantified using omics methods. These tools can be used to describe an organism's dynamics, structure, and function. Moreover, other advancements like single-cell sequencing, CRISPR, and genome editing have been a boon. Furthermore, research activities are being prioritized through various funding and collaborations.
Molecular Genetic Testing for Autoimmune Diseases Market Restraints and Challenges:
Associated costs, data security, limited comprehension, a lack of trained professionals, and unequal access are the main issues that the market is currently experiencing.
Affordability is one of the biggest barriers in this market. The equipment and diagnostic tools that are used require upgrades and proper maintenance. These charges can financially drain smaller firms. Secondly, the privacy of data is another concern. Sensitive information regarding the patient's clinical records and other genetic data can be leaked or misused. This can result in huge financial losses and create threats to mankind by creating harmful viruses or other toxins. Thirdly, there is a limited understanding as well as data availability in the genetics field. This can lead to complexity in interpretation. Moreover, obstacles can be faced while integrating the data because there is an inadequacy of people with expertise. Furthermore, a few remote and underdeveloped areas might not have equal access to various resources and infrastructure.
Molecular Genetic Testing for Autoimmune Diseases Market Opportunities:
The concept of personalized medicine has provided the market with an infinite number of possibilities. This involves making medications and drugs as per the genetic makeup of an individual. Biomarkers are used for this purpose. This is a great advantage, as it helps in early detection and diagnosis. Secondly, R&D activities have been undergoing significant milestones in developing novel biomarkers, proteins, and the exact genetic variation that leads to disease creation. Thirdly, integration with healthcare facilities has been helping with patient engagement and awareness. The market is seeing an augmentation through global operations, data sharing, publications, and other part
GLOBAL MOLECULAR GENETIC TESTING FOR AUTOIMMUNE DISEASES MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
5 % |
|
Segments Covered |
By Disease Type, Technology, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Abbott Laboratories, Thermo Fisher Scientific Illumina, Bio-Rad Laboratories, Roche Diagnostics, AcaciaResearch, Qiagen, PerkinElmer, Eurofins Scientific, Myriad Genetics |
Molecular Genetic Testing for Autoimmune Diseases Market Segmentation:
Market Segmentation: By Disease Type:
Rheumatoid arthritis (RA) is the largest disease type in this market. One of the major reasons for this is the number of cases that have been registered and estimated over the forecast period. According to recent estimates, more than 350 million people are diagnosed with this condition, thereby creating a crucial need for testing. Type 1 diabetes is one of the fastest-growing disease types. The immune system of the body targets and kills the beta cells in the pancreas that produce insulin, resulting in type 1 diabetes. 8.75 million people globally will suffer from type 1 diabetes in 2022. This has raised the need for testing to help in controlling and managing this disease.
Market Segmentation: By Technology:
Based on technology, PCR is the largest segment. This very sensitive and precise technique can be used to identify and measure certain nucleic acids in a clinical sample. Its use enables the very sensitive, accurate, and quick diagnosis and treatment of autoimmune illnesses. Besides, it can be used to detect diseases even with a small sample amount. NGS is the fastest-growing method. NGS can identify mutations and variations in both DNA and RNA. In a short amount of time, it may sequence thousands of genes or a whole genome.
Market Segmentation: By End-Users:
Based on end-users, hospitals and clinics are the largest in the market. This is because these channels are equipped with advanced resources and infrastructure, which is necessary for testing. Besides, licensed professionals are present who perform accurate testing and other procedures. This increases the trust of patients. Apart from this, to keep up with the upgrades and maintain the available facilities, they are financed regularly by business tycoons, multinational companies, and other governmental bodies. Diagnostic centers are considered to be the fastest-growing segment. The success of this segment is mainly because of their affordability when compared to bigger organizations. Several improvements have been made to improve the available equipment by funding these institutes. Besides, greater work opportunities are being provided in these centers, thereby attracting more individuals to join these places.
Market Segmentation: Regional Analysis:
Based on region, North America is the largest segment, holding a rough share of 30%. The most dominant countries in this region include the United States and Canada. This area is well-equipped with advanced healthcare systems. These channels have technologies and diagnostic testing facilities that aid growth. Secondly, this region has prestigious research institutes that have experienced many breakthroughs because of the presence of renowned scholars. Universities like Johns Hopkins, Harvard, and the Massachusetts Institute of Technology are the most prominent ones. Apart from this, major players are present in this region who have good funds, collaborations, and global operations in this market. Asia-Pacific is the fastest-growing region with countries like Singapore, India, China, and Japan being the notable ones. This region holds an approximate share of 22%. These regions have a growing healthcare system. Funds are being increased as the economy becomes more stable. This includes rapid advancements in diagnostic facilities. Several research institutes have been witnessing progress by focusing on partnerships, advanced research, and technologies that generate more precise and accurate results. Furthermore, an increasing incidence of autoimmune diseases has put a greater emphasis on awareness and genetic testing methods.
COVID-19 Impact Analysis on the Global Molecular Genetic Testing for Autoimmune Diseases Market:
The outbreak of the virus had a positive impact on the market. Most of the funding was shifted towards healthcare applications. This included research activities as a prominent category. Several prestigious institutes and universities were working towards deepening human knowledge. Studies were carried out to determine if there was any increased risk for autoimmune diseases in patients who were affected by the coronavirus. According to a paper by Nature Journal, compared to a non-COVID-19 cohort of 1,560,357 people who were matched for age, sex, and whether or not they had a prior autoimmune illness, the researchers found that there was a 42.6% increased chance of developing an autoimmune ailment 3–15 months after infection. Besides, variations in genes for people who had autoimmune diseases and were affected by the virus were also studied. Many bioinformatics tools and other computational techniques have gained attention. Post-pandemic, the market has continued to grow owing to increased investments and partnerships.
Latest Trends/ Developments:
The safety of data is being prioritized through various software, encryption methods, authenticity testing, and other measures. Fields like AI have been facilitating pattern detection, analysis, and response. Apart from this, data masking and access control are being given utmost prominence. Other fields like IoT, ML, behavioral biometrics, and blockchain technologies are being explored to enhance security.
Key Players:
In October 2023, the immune system's memory of a single molecule was eliminated by the novel vaccination created by US researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago. A novel kind of inverse vaccine has been demonstrated in a laboratory environment to fully correct autoimmune illnesses, including type 1 diabetes and multiple sclerosis, all without impairing the immune system as a whole.
In September 2023, Verily and Kyverna Therapeutics collaborated to find new biomarkers and develop innovative approaches for designing and carrying out clinical trials for autoimmune diseases like lupus. Through multi-year cooperation, cell therapy engineering and precision health technologies will be combined to better understand the biology underlying the immune system's reset by CAR-T cell therapy.
In February 2023, Roche and Janssen Biotech extended their partnership to encompass a broad spectrum of companion diagnostics, such as tissue and blood-based biomarkers, sequencing, digital pathology, next-generation sequencing, polymerase chain reaction, and immunoassays. In addition, possible cooperation in the precision medicine area is covered by the enlarged agreement. This includes the use of immunohistochemistry (IHC) testing to identify patients who have certain disease markers.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Molecular Genetic Testing for Autoimmune Diseases Market was valued at USD 700 million and is projected to reach a market size of USD 984.97 million by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 5%.
An increasing prevalence of diseases and technological advancements are the main factors propelling the Global Molecular Genetic Testing for Autoimmune Diseases Market.
Based on Disease Type, the Global Molecular Genetic Testing for Autoimmune Diseases Market is segmented into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Type 1 Diabetes, Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), and Others.
North America is the most dominant region for the Global Molecular Genetic Testing for Autoimmune Diseases Market.
Abbott Laboratories, Thermo Fisher Scientific, and Illumina are the key players operating in the Global Molecular Genetic Testing for Autoimmune Diseases Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
